French Professional Services Stock News

ENXTPA:SGO
ENXTPA:SGOBuilding

Saint Gobain (ENXTPA SGO) Margin Improvement Tests Bullish Earnings Expansion Narrative

Compagnie de Saint-Gobain (ENXTPA:SGO) has posted its FY 2025 results with second half revenue of €22.6b, basic EPS of €2.54 and net income of €1,254m, against a backdrop of modest earnings growth over the past year and a small uptick in net profit margin to 6.2%. The group has seen revenue move from €23.1b in 2H 2024 to €22.6b in 2H 2025, while trailing twelve month EPS sits at €5.83 on net income of €2,883m. This gives investors a clear read on earnings power heading into the new year. With...
ENXTPA:ALLAN
ENXTPA:ALLANBeverage

Lanson BCC H1 EPS Drop To €0.28 Challenges Bullish Growth Narratives

Lanson-BCC (ENXTPA:ALLAN) has put fresh numbers on the table, with first half FY 2025 revenue at €92.05 million and basic EPS at €0.28, alongside trailing twelve month revenue of €259.69 million and EPS of €3.31 that frame how the latest stretch compares with the recent run rate. The company has seen revenue move from €87.80 million and EPS of €0.56 in first half FY 2024 to €167.64 million and EPS of €3.03 in second half FY 2024, giving investors a clear look at how top line scale and per...
ENXTPA:ANTIN
ENXTPA:ANTINCapital Markets

Antin Infrastructure Partners SAS ENXTPA ANTIN Margin Slippage Tests Bullish Growth Narrative

Antin Infrastructure Partners SAS (ENXTPA:ANTIN) has just posted its FY 2025 numbers, with second half revenue of €144.3 million and basic EPS of €0.33, backed by trailing twelve month revenue of €292.5 million and EPS of €0.62. The group has seen revenue move from €318.4 million to €292.5 million on a trailing basis, with EPS shifting from €0.74 to €0.62. FY 2025 first half revenue of €148.2 million and EPS of €0.29 frame the latest half in context, leaving investors weighing solid absolute...
ENXTPA:HO
ENXTPA:HOAerospace & Defense

Assessing Thales (ENXTPA:HO) Valuation After The SkyDefender Defence System Launch

Thales (ENXTPA:HO) has just launched SkyDefender, a multi-layer, multi-domain air and missile defence system that uses artificial intelligence, advanced sensors and cybersecurity to provide integrated protection and early warning across land, sea and space. See our latest analysis for Thales. Thales shares have gained 2.99% on a 1-day basis and 7.83% over the past week, with the current share price at €254.9, as investors react to the SkyDefender launch, recent quantum secure 5G progress and...
ENXTPA:IDL
ENXTPA:IDLLogistics

ID Logistics Group (ENXTPA:IDL) Earnings Growth Tests Rich P/E Narrative

ID Logistics Group (ENXTPA:IDL) has wrapped up FY 2025 with second half revenue of €1.98b and net income of €40.9m, alongside trailing twelve month revenue of €3.74b and net income of €63.3m that frame the latest run rate. The company has seen revenue move from €1.75b in H2 2024 to €1.98b in H2 2025, while trailing twelve month revenue stepped up from €3.27b to €3.74b and trailing EPS came in at €8.90. This sets the scene for investors to weigh profit trends against how efficiently those...
ENXTPA:ALO
ENXTPA:ALOMachinery

Is It Time To Reassess Alstom (ENXTPA:ALO) After Its Recent Share Price Slide

If you are wondering whether Alstom shares are offering fair value right now, it helps to first look at how the market has been treating the stock over different time frames. Recently, the share price has been under pressure, with a 6.5% decline over the last week, a 15.0% decline over the last month, and a 4.7% decline year to date. This is set against a 5.8% return over 1 year and 12.7% over 3 years, while the 5 year return sits at a 36.4% decline. These moves have come as investors...
ENXTPA:ARG
ENXTPA:ARGIndustrial REITs

Argan (ENXTPA:ARG) Valuation Check After New Lease Secures Full Logistics Portfolio Occupancy

Argan (ENXTPA:ARG) has just secured a nine year lease with JS Logistics for 32,000 sq.m at its Le Coudray Montceaux site, bringing its roughly 4 million sq.m warehouse portfolio back to full occupancy. See our latest analysis for Argan. The lease news lands after a mixed run in the share price, with Argan’s latest €63.8 level sitting alongside a 7 day share price return of 4.78% decline and a 90 day gain of 1.92%. The 1 year total shareholder return of 6.34% contrasts with weaker 3 and 5 year...
ENXTPA:AM
ENXTPA:AMAerospace & Defense

Falcon 10X Raises Stakes For Dassault Aviation And Falcon Franchise Investors

Dassault Aviation société anonyme has presented the Falcon 10X, a new flagship business jet, highlighting major advances in cabin design, materials and flight systems. The aircraft introduces business aviation’s first all composite wing, the NeXus flight deck and next generation digital flight control systems. The Falcon 10X targets the top end of the business jet market, where it will compete with leading large cabin models from established manufacturers. For investors tracking ENXTPA:AM,...
ENXTPA:TE
ENXTPA:TEEnergy Services

Technip Energies (ENXTPA:TE) Valuation After 2025 Report 2026 Guidance Dividend Proposal And Board Updates

Technip Energies (ENXTPA:TE) drew fresh attention after publishing its 2025 Annual Report, reporting fourth quarter and full year results, issuing 2026 revenue guidance, proposing a cash dividend, and outlining upcoming board changes. See our latest analysis for Technip Energies. The latest report, dividend proposal and 2026 revenue guidance have come as the share price sits at €34.26, with a 30 day share price return of about 4% and a 1 year total shareholder return of roughly 19%, adding to...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Is There Now An Opportunity In Airbus (ENXTPA:AIR) After The Recent Share Price Pullback

If you are wondering whether Airbus shares are offering fair value right now, you are not alone. Many investors are asking the same question as the stock sits well off its recent highs. The share price closed at €176.92 most recently, with returns of 10.2% over 1 year, 60.5% over 3 years and 87.5% over 5 years. However, the stock has seen a 0.2% slip over 7 days, an 8.4% decline over 30 days and a 13.1% decline year to date. Recent headlines around Airbus have focused on its role as a major...
ENXTPA:HO
ENXTPA:HOAerospace & Defense

How Investors May Respond To Thales (ENXTPA:HO) Expanding AI Air Defense And eSIM Payments Connectivity

In recent days, Thales has launched SkyDefender, a multi-layer integrated air and missile defence system spanning land, sea and space, while also advancing secure connectivity through new quantum-safe 5G security capabilities and eSIM-based partnerships with Verifone and Brazilian payments provider Cielo. Together, these developments highlight how Thales is pairing defence systems, AI and cybersecurity with eSIM-driven payments connectivity to position itself as a core technology partner...
ENXTPA:ENGI
ENXTPA:ENGIIntegrated Utilities

Is It Too Late To Consider Engie (ENXTPA:ENGI) After A 72% One-Year Rally?

If you are wondering whether Engie’s current share price still offers value after a strong run, you are not alone. This article is built to help you think that through clearly. Engie’s stock last closed at €27.04, with returns of 0.1% over 7 days, 5.2% over 30 days, 17.7% year to date and 72.3% over 1 year, while the 3 year and 5 year returns sit at 151.6% and 227.8% respectively. Recent coverage has focused on Engie’s role as a major utilities player in France and Europe, including ongoing...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

How New CHMP Opinions on Dupixent and Acoziborole Will Impact Sanofi (ENXTPA:SAN) Investors

In late February 2026, Sanofi and Regeneron reported that the European Medicines Agency’s CHMP issued positive opinions for Dupixent in young children with chronic spontaneous urticaria and for Acoziborole Winthrop as a single-dose oral treatment for gambiense sleeping sickness, with final EU decisions expected in the months that followed. These CHMP endorsements highlight how Sanofi’s immunology and neglected tropical disease programs may broaden its treatment footprint across both...
ENXTPA:CS
ENXTPA:CSInsurance

How AXA’s 2026 Buyback, Higher Dividend and Earnings Jump At AXA (ENXTPA:CS) Has Changed Its Investment Story

AXA SA has already announced for 2026 a new share repurchase program of up to €1,250 million, authorized by its Board, alongside a higher annual dividend of €2.32 per share and reported past-year net income of €9.80 billion versus €7.89 billion previously. This combination of a sizeable buyback, increased cash returns, and higher net income signals a strong focus on rewarding shareholders and underscores management’s confidence in the business. We’ll now examine how AXA’s sizeable share...
ENXTPA:SW
ENXTPA:SWHospitality

Is Sodexo (ENXTPA:SW) Pricing Make Sense After A 38.3% One Year Share Price Fall

If you are wondering whether Sodexo shares are offering fair value today, this article will walk through what the current price might be implying about the company. Sodexo's share price closed at €44.42, with returns of a 1.6% decline over the last 7 days, a 1.7% decline over 30 days, a 3.4% gain year to date, and a 38.3% decline over the past year. This raises questions about how the market is currently pricing its prospects and risks. Recent news around Sodexo has focused on its role as a...
ENXTPA:RNO
ENXTPA:RNOAuto

Renault futuREady Plan Tests Valuation Discount With 36-Model Expansion

Renault has launched a new group plan called "futuREady" that targets 36 new model launches by 2030. The plan puts more weight on electrification, product development and partnerships across Renault’s ecosystem. A key element is a stronger push beyond Renault’s traditional European strongholds to capture more international growth. For investors watching ENXTPA:RNO, this fresh plan lands at a time when the shares trade around €28.17 and have faced pressure, with a 1 year return of a 38.1%...
ENXTPA:VU
ENXTPA:VUElectronic

Assessing Vusion (ENXTPA:VU) After 2025 Results 2026 Guidance And Qualcomm AI Retail Partnership

Vusion (ENXTPA:VU) has been in focus after reporting 2025 sales of €1,472 million with net income of €84.2 million, issuing 2026 earnings guidance, and outlining an AI retail partnership with Qualcomm. See our latest analysis for Vusion. Despite the recent earnings, 2026 guidance and Qualcomm AI retail partnership, Vusion’s 30 day share price return of 12.12% and year to date share price return of 46.94% suggest momentum has been weak, even though the 5 year total shareholder return of...
ENXTPA:DBV
ENXTPA:DBVBiotechs

DBV Technologies (ENXTPA:DBV) Valuation After Positive Phase 3 Peanut Patch Results

DBV Technologies (ENXTPA:DBV) recently reported additional positive data from its Phase 3 VITESSE trial of the VIASKIN Peanut Patch in peanut allergic children, with the study meeting its primary endpoint and showing a statistically significant treatment effect. See our latest analysis for DBV Technologies. The latest clinical update appears to be feeding into stronger momentum, with a 7.3% 1 day share price return and a 36.95% 90 day share price return at €4.04, alongside a very large 1 year...
ENXTPA:VIE
ENXTPA:VIEIntegrated Utilities

Veolia Deepens US Waste And Water Role With Long Term Contract Focus

Veolia Environnement announced a new US hazardous waste acquisition, expanding its presence in the North American market. The company is extending its PFAS treatment capabilities across North America to address growing water quality challenges. Veolia and the National Association of Water Companies published a policy white paper calling for large scale water infrastructure investment in the US. Veolia Environnement (ENXTPA:VIE), trading at €32.4, has seen its share price return 7.5% year to...
ENXTPA:GDS
ENXTPA:GDSHealthcare

Ramsay Générale De Santé (ENXTPA:GDS) Valuation Check After Half Year Sales Growth And Narrowing Net Loss

Ramsay Générale de Santé (ENXTPA:GDS) has released half year results to December 31, 2025, reporting sales of €2,589.1 million and a net loss of €34.9 million, both changing compared with a year earlier. See our latest analysis for Ramsay Générale de Santé. The half year update comes after a period where the share price has shown mixed momentum, with a 15.22% 90 day share price return and a 13.49% year to date share price return, yet a 3 year total shareholder return of a 45.36% decline. If...
ENXTPA:RBT
ENXTPA:RBTChemicals

Robertet (ENXTPA:RBT) Valuation Check As Shares Trade On 16.7x P/E With DCF Suggesting Upside Potential

Event context and current performance snapshot Robertet (ENXTPA:RBT) has been drawing attention after recent price moves, with the share price last closing at €825. Recent returns show a 1 day decline of 0.24%, a 7 day decline of 4.73%, and a month decline of 1.43%. See our latest analysis for Robertet. Recent selling pressure has pulled the 90 day share price return to an 8.74% decline and the year to date share price return to a 6.14% decline. The 1 year total shareholder return is 2.12%,...
ENXTPA:74SW
ENXTPA:74SWSoftware

Assessing 74Software (ENXTPA:74SW) Valuation After 2025 Results And New 2028 Growth Targets

Why the 2025 results and 2028 guidance matter for investors 74Software (ENXTPA:74SW) has drawn investor attention after releasing its 2025 full year results alongside fresh guidance for 2028, combining recent performance data with a clearer view of its longer term financial ambitions. On the reported figures, sales for 2025 came in at €707.22 million, while net income was €40.76 million. Basic earnings per share from continuing operations were €1.39, with diluted earnings per share at...
ENXTPA:VIRI
ENXTPA:VIRIEnergy Services

Assessing Viridien (ENXTPA:VIRI) Valuation After Earnings Upswing And Rebrand From CGG

Viridien Société anonyme (ENXTPA:VIRI) has moved into focus after its recent earnings showed higher net income alongside lower sales, together with the rebrand from CGG that highlights its focus on Earth data and sensing. See our latest analysis for Viridien Société anonyme. Those earnings and the CGG rebrand sit against a strong recent run, with a 90 day share price return of 35.29% at €122.1 and a 1 year total shareholder return of 100.13%. This hints that momentum has been building rather...
ENXTPA:DBV
ENXTPA:DBVBiotechs

Will Positive Phase 3 VITESSE Peanut Patch Data Change DBV Technologies' (ENXTPA:DBV) Narrative?

DBV Technologies recently presented additional positive data from its successful Phase 3 VITESSE trial of the VIASKIN Peanut Patch for peanut-allergic children aged 4 to 7 at the 2026 AAAAI Annual Meeting in Philadelphia. The data showed clinically meaningful increases in the eliciting dose for treated children versus placebo, highlighting both potential protection against reactions and the risks of remaining untreated. Next, we will examine how these Phase 3 VITESSE results, particularly...